NT HIV- (n = 42) | NT HIV+ (n = 38) | PE HIV- (n = 29) | PE HIV+ (n = 27) | |
Genotypes n (%) | ||||
TT | 8 (19) | 10 (26) | 8 (28) | 5 (19) |
TC | 23 (55) | 18 (48) | 11 (38) | 15 (56) |
CC | 11 (26) | 10 (26) | 10 (34) | 7 (25) |
Alleles n (%) | ||||
T | 39 (46) | 38 (50) | 27 (47) | 25 (46) |
C | 45 (54) | 38 (50) | 31 (53) | 29 (54) |
HWE | 0.8076 | 0.9487 | 0.4405 | 0.8306 |
Genotypes | Alleles | |||
p-values | p-values (OR; CI) | |||
All groups | 0.8338 | 0.9636 | ||
PE HIV- vs. PE HIV+ | 0.4131 | 1.000 (0.9898; 0.4707–2.082) | ||
NT HIV- vs. NT HIV+ | 0.7113 | 0.7515 (1.154; 0.6198–2.148) | ||
NT HIV- vs. PE HIV- | 0.3737 | 1.0000 (1.005; 0.5137–1.966) | ||
NT HIV + vs. PE HIV + | 0.7316 | 0.7238 (0.8621; 0.4285–1.734) |